McDermott + Bull Partner Ken Dropiewski interviews Gilde Healthcare General Partner Geoff Pardo in his series, Investor Insights in Life Sciences + MedTech. In the conversations below, Ken and Geoff discuss what venture in MedTech will look like in 2023, what Gilde...
IRVINE, CA (August 30, 2022) – McDermott + Bull announces the addition of Shelby Varon as Director of Business Development for the firm’s national MedTech and Life Sciences Group where she will work closely with McDermott + Bull Partner Ken Dropiewski in...
McDermott + Bull has successfully placed Garrett Kiesle as President + Chief Operating Officer at Shalby Advanced Technologies Inc. (SAT). Garrett will help drive the organization’s commercial execution and expansion nationally and internationally. He will be the face...
Heading into 2022, many expected the rapid continuation of strong initial public offerings (IPOs) and merger + acquisition (M+A) activity. Wow, that was off. The underestimated implications of supply chain issues, geopolitical concerns, and Federal Trade Commission...
McDermott + Bull Partner Ken Dropiewski interviews Endeavour Venture Partner Rob Barmann in his series, Investor Insights in Life Sciences + MedTech. In the conversations below, Ken and Rob discuss a range of topics from typical investment sizes to non-traditional...
McDermott + Bull has successfully placed Tammy Hicklin-Estabrook as Vice President of Sales at Nuance Medical. Tammy will be responsible for driving commercial growth and success by establishing multi-faceted sales strategies and leading a high-performing hybrid sales...
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. Privacy policyOkNo
